Managers face a variety of challenges during their careers. Instead of falling into fight or flight, develop resilience to ...

But the YoY growth is expected to decline for the Indian Pharmaceutical Market (IPM), projected at approximately 8 per cent, ...

The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

After third-party manufacturing issues led to a December rejection of Zealand Pharma’s pediatric congenital hyperinsulinism (CHI) candidate, the Danish pharma’s latest snub seems to come down to ti | ...

A delegation from the Pakistan Pharmaceutical Manufacturers Association (PPMA), led by its Chairman, met with Federal ...

Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

Boehringer Ingelheim has rolled into an alliance with undruggable target specialist Circle Pharma, putting together a package ...

The pharmaceutical industry is poised for an 8.5% revenue growth, spurred by domestic formulations and niche US market ...

during the 6th CII Pharma & Life Sciences Summit 2024 today. He emphasized that the initiative has bolstered domestic ...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

The recent article in The Atlantic that belittles subject matter experts advocating for holistic health and questioning the ...